1,3-二苯基-1H-吡唑-4-羧酸 | 77169-12-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 1,3-二苯基-1H-吡唑-4-羧酸
• 英文名称: 1,3-diphenyl-1H-pyrazole-4-carboxylic acid
• 英文别名: 1,3-Diphenyl-pyrazol-carbonsaeure-(4)；1,3-Diphenylpyrazol-4-carbonsaeure；1,3-diphenylpyrazole-4-carboxylic acid
• CAS: 77169-12-1
• 化学式: C₁₆H₁₂N₂O₂
• mdl: MFCD00475348
• 分子量: 264.283
• InChiKey: OTDDCLPBNWLJLH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  55.1
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2933199090

反应信息

• 作为反应物：
  描述：

  1,3-二苯基-1H-吡唑-4-羧酸 在 氯甲酸乙酯 、 三乙胺 、 sodium azide 作用下， 以 丙酮 、 水 为溶剂， 反应 5.0h， 以92%的产率得到1,3-Diphenyl-1H-pyrazole-4-carbonyl azide
  参考文献：
  名称：

  摘要：

  DOI：

  10.1023/a:1013982203774
• 作为产物：
  描述：

  在 2,2,6,6-tetramethyl-piperidine-N-oxyl 三氯异氰尿酸 、 碳酸氢钠 、 sodium carbonate 、 sodium bromide 作用下， 以 丙酮 为溶剂， 生成 1,3-二苯基-1H-吡唑-4-羧酸
  参考文献：
  名称：

  A Mild Procedure for the Preparation of 3-Aryl-4-formylpyrazoles

  摘要：

  多种3-芳基-4-甲酰基吡唑能够以良好的产率，从相应的甲基酮出发，在常温下经N,N-二甲基甲酰胺中2,4,6-三氯[1,3,5]三嗪处理而容易地制备得到。此类吡唑可构成组合化学的新型构建模块。

  DOI：

  10.1055/s-2004-832809

文献信息

• Novel Aryl Substituted Pyrazoles as Small Molecule Inhibitors of Cytochrome P450 CYP121A1: Synthesis and Antimycobacterial Evaluation
  作者：Ismail M. Taban、Hosam E. A. E. Elshihawy、Beyza Torun、Benedetta Zucchini、Clare J. Williamson、Dania Altuwairigi、Adeline S. T. Ngu、Kirsty J. McLean、Colin W. Levy、Sakshi Sood、Leonardo B. Marino、Andrew W. Munro、Luiz Pedro S. de Carvalho、Claire Simons

  DOI：10.1021/acs.jmedchem.7b01562

  日期：2017.12.28

  KD values of 2.63, 35.6, and 290 μM, respectively, for the tightest binding compounds 7e, 8b, and 13d from their respective series. Both binding affinity assays and docking studies of the CYP121A1 inhibitors suggest type II indirect binding through interstitial water molecules, with key binding residues Thr77, Val78, Val82, Val83, Met86, Ser237, Gln385, and Arg386, comparable with the binding interactions

  描述了三个系列的联芳基吡唑咪唑和三唑，它们在联芳基吡唑和咪唑/三唑基团之间的接头不同。具有短-CH 2 - 接头的咪唑和三唑系列显示出有希望的抗分枝杆菌活性，咪唑-CH 2 - 系列 ( 7 ) 显示出低 MIC 值 (6.25-25 μg/mL)，这也受到亲脂性的影响。将接头延伸至-C(O)NH(CH 2 ) 2 - 导致抗分枝杆菌活性丧失。化合物与 CYP121A1 的结合亲和力通过紫外-可见光滴定法测定，对于最紧密结合的化合物7e ， K D值分别为 2.63、35.6 和 290 μM、8b和13d来自它们各自的系列。CYP121A1 抑制剂的结合亲和力测定和对接研究表明 II 型通过间质水分子间接结合，具有关键结合残基 Thr77、Val78、Val82、Val83、Met86、Ser237、Gln385 和 Arg386，与用氟康唑观察到的结合相互作用相当和天然底物二环酪氨酸。
• Inhibitors of P2X3
  申请人：Brotherton-Pleiss E. Christine

  公开号：US20070037974A1

  公开（公告）日：2007-02-15

  Compounds of formula 1 are modulators of P2X3 useful for the treatment of pain and genito-urinary, gastrointestinal, and respiratory disorders: wherein R 1 is —C(═S)CH 3 , pyridyl, pyrimidinyl, pyrazinyl, thiazolyl, furyl, furylcarbonyl, acetyl, or carbamoyl; R 2a and R 2b are independently H, methyl, or ethyl; R 3 is H or methyl; Y is a bond, —(CR 4 R 5 ) n — or —CR 4 ═CR 5 —; wherein R 4 and R 5 are each independently H or methyl and n is 1 or 2; X is N or CH; A is phenyl, 5-membered heterocyclyl, or 6-membered heterocyclyl; R 6 , R 7 and R 8 are each independently H, halo, lower alkyl, cycloalkyl, alkylthio, alkylthio-lower alkyl, alkylsulfonyl-lower alkyl, di(lower alkyl)amino-lower alkyl, morpholinyl-lower alkyl, 4-methyl-piperazinyl-methyl, trifluoromethyl, pyridyl, tetrazolyl, thiophenyl, phenyl, biphenyl, or benzyl (where thiophenyl, phenyl and benzyl are substituted with 0-3 lower alkyl, halo, sulfonamido, trifluoromethyl, lower alkoxy or lower alkylthio) or R 6 and R 7 together form a 5-membered or 6-membered carbocyclic or heterocyclic ring substituted with 0-3 substituents selected from the group consisting of lower alkyl, lower alkoxy, oxo, halo, thiophenyl-lower alkyl, phenyl, benzyl (where phenyl and benzyl are substituted with 0-3 lower alkyl, halo, sulfonamido, trifluoro-methyl, lower alkoxy, lower alkylthio, amino-lower alkyl, lower alkylamino-lower alkyl, or di(lower alkyl)amino-lower alkyl); and pharmaceutically acceptable salts thereof; wherein when R 1 is pyrimidin-2-yl, X is N, Y is a bond and A is oxazol-5-yl the carbon atom at position 4 in said oxazol-5-yl is not substituted by propyl when the carbon atom at position 2 in said oxazol-5-yl is substituted by substituted phenyl and the carbon atom at position 4 in said oxazol-5-yl is not substituted by phenyl when the carbon atom at position 2 is substituted by unsubstituted or substituted phenyl.

  式1的化合物是P2X3的调节剂，用于治疗疼痛和泌尿生殖、胃肠和呼吸系统疾病： 其中 R 1 为—C(═S)CH 3 ，吡啶基，嘧啶基，吡嗪基，噻唑基，呋喃基，呋喃甲酰基，乙酰基或氨基甲酰基；R 2a 和R 2b 独立地为H，甲基或乙基；R 3 为H或甲基；Y为键，—(CR 4 R 5 ) n —或—CR 4 ═CR 5 —；其中R 4 和R 5 各自独立地为H或甲基，n为1或2；X为N或CH；A为苯基，5-成员杂环基或6-成员杂环基；R 6 ，R 7 和R 8 各自独立地为H，卤素，低碳基，环烷基，烷基硫醚，烷基硫醚-低碳基，烷基磺酰基-低碳基，二(低碳基)氨基-低碳基，吗啉基-低碳基，4-甲基哌嗪基-甲基，三氟甲基，吡啶基，四唑基，噻吩基，苯基，联苯基或苄基（其中噻吩基，苯基和苄基被0-3个低碳基，卤素，磺酰胺基，三氟甲基，低烷氧基或低烷硫基取代）或R 6 和R 7 一起形成一个被0-3个取自由低碳基，低烷氧基，氧代基，卤素，噻吩基-低碳基，苯基，苄基（其中苯基和苄基被0-3个低碳基，卤素，磺酰胺基，三氟甲基，低烷氧基，低烷硫基，氨基-低碳基，烷基氨基-低碳基或二(低碳基)氨基-低碳基取代）的5-成员或6-成员碳环或杂环取代环；及其药学上可接受的盐；其中当R 1 为嘧啶-2-基时，X为N，Y为键，A为噁唑-5-基时，所述噁唑-5-基中位置4的碳原子在所述噁唑-5-基中位置2的碳原子被取代的苯基取代时不被丙基取代，且所述噁唑-5-基中位置4的碳原子在位置2被取代的苯基取代时不被苯基取代。
• Synthesis of 3<i>H</i>-Pyrazolo[3,4-<i>c</i>]isoquinolines and Thieno[3,2-<i>c</i>]isoquinolines via Cascade Imination/Intramolecular Decarboxylative Coupling
  作者：Garima Pandey、Subhendu Bhowmik、Sanjay Batra

  DOI：10.1021/ol4023722

  日期：2013.10.4

  A general approach for the synthesis of 3H-pyrazolo[3,4-c]isoquinolines and thieno[3,2-c]isoquinolines is described involving the implementation of a cascade imination/intramolecular decarboxylative coupling between potassium 2-amino(hetero)benzoates and 2-haloarylaldehydes. The reactions of pyrazole-based substrates require a Pd–Cu bimetallic system for superior yields whereas the thienyl-based substrates

  为3合成的一般方法ħ -吡唑并[3,4- c ^ ]异喹啉和噻吩并[3,2- C ^ ]异喹啉，描述涉及级联亚胺化/分子内脱羧耦合钾之间2-氨基（杂）的实施苯甲酸酯和2-卤代芳基醛。吡唑基底物的反应需要Pd-Cu双金属系统才能获得更高的收率，而噻吩基的底物仅使用Pd催化剂即可提供优异的收率。
• Synthesis and Biological Activity Test of Some New Five Membered Heterocycles
  作者：Qingchun Xia、Dongfang Xu、Qizhuang He、Xingyu Li、Dazhi Sun

  DOI：10.1002/cjoc.201190017

  日期：2010.12

  A new series of 1,3,4‐oxadiazoles, 1,2,4‐triazoles, 1,3,4‐thiadiazoles were synthesized using alkylhydrazides as the starting materials, and then 1,2,4‐triazoles were used to synthesize [1,2,4]triazolo[3,4‐b][1,3,4]thiadiazoles. All the compounds were evaluated for in vitro antibacterial activity and antitumor activity.

  以烷基酰肼为原料合成了一系列新的1,3,4-恶二唑，1,2,4-三唑，1,3,4-噻二唑，然后使用1,2,4-三唑合成了[ 1,2,4]三唑[3,4- b ] [1,3,4]噻二唑。评价所有化合物的体外抗菌活性和抗肿瘤活性。
• Discovery of N-(benzyloxy)-1,3-diphenyl-1H-pyrazole-4-carboxamide derivatives as potential antiproliferative agents by inhibiting MEK
  作者：Xian-Hai Lv、Zi-Li Ren、Ben-Guo Zhou、Qing-Shan Li、Ming-Jie Chu、Dao-Hong Liu、Kai Mo、Li-Song Zhang、Xiao-Kang Yao、Hai-Qun Cao

  DOI：10.1016/j.bmc.2016.08.002

  日期：2016.10

  inhibitor has been demonstrated significant clinical benefit for blocking MAPK pathway activation and possibly could block reactivation of the MAPK pathway at the time of BRAF inhibitor resistance. Twenty N-(benzyloxy)-1,3-diphenyl-1H-pyrazole-4-carboxamide derivatives have been designed and synthesized as MEK inhibitors, and their biological activities were evaluated. Among these compounds, compound 7b

  丝裂原活化蛋白激酶（MAPK）信号转导途径已被证明在肿瘤发生和癌症发展中起重要作用。已经证明MEK抑制剂对于阻断MAPK途径活化具有显着的临床益处，并且可能在BRAF抑制剂抵抗时阻断MAPK途径的再活化。设计并合成了二十种N-（苄氧基）-1,3-二苯基-1H-吡唑-4-羧酰胺衍生物作为MEK抑制剂，并对其生物学活性进行了评估。在这些化合物中，化合物7b表现出最强的抑制活性，对MEK1的IC50为91nM，对A549细胞的GI50为0.26μM。进行了SAR分析和对接模拟，以提供可用于进一步结构优化的关键药效​​团线索。